News | December 29, 2009

Heart Transplant Patients Show Increased Risk of Skin Cancer

December 29, 2009 - Among the 312 heart transplant patients at the Mayo Clinic who researchers followed for 19 years, nearly half developed skin cancers during follow-up, particularly squamous cell and basal cell carcinomas, according to a study published in the December issue of Archives of Dermatology.

The study, led by Jerry D. Brewer, M.D., of the Mayo Clinic in Rochester, Minn., found a total of 1,395 new skin cancers developed, of which 89 percent were squamous cell carcinomas and 11 percent were basal cell carcinomas.

Researchers identified an association between the use of the immunosuppressant mycophenolate mofetil (CellCept) (HR 2.74, P=0.001) and an increased risk for basal cell carcinoma.

Increased age at transplant was a common risk factor (10-year HR 2.57, P

The study found that incidence increased with time from transplant with cumulative rates of any skin cancer 20.4 percent at five years and 37.5 percent at 10 years.

Rates increased similarly for various types of cancer. Five, 10, and 15 years after transplant, a total of 15.4 percent, 32.3 percent, and 38.2 percent of patients had squamous cell carcinoma; and 10.3 percent, 19.2 percent, and 31.6 percent developed basal cell carcinoma.

The cumulative incidence rates of a second squamous cell carcinoma were 44.0 percent, 67.4 percent, and 75.9 percent at one, three, and five years after the first squamous cell carcinoma.

Cumulative rates of developing basal cell carcinoma were 36.7 percent, 54.7 percent, and 65.9 percent at one, three, and five years after the first basal cell carcinoma and reached 98.1 percent within seven years.

Related Content

The Centricity Cardio Enterprise (CCE) Interactive Guide offers information on GE's cardiovascular information system (CVIS)
News | Cardiac PACS| July 28, 2017
July 28, 2017 — GE Healthcare has released the eight-page...
WVU Medicine Deploys Enterprise PACS from ScImage
News | Cardiac PACS| July 24, 2017
ScImage Inc. recently announced West Virginia University Health System has partnered with ScImage to utilize ScImage’s...
Innovative Cardiovascular Ultrasound Solutions Showcased at ASE 28th Annual Scientific Sessions
News | Cardiovascular Ultrasound| June 01, 2017
June 1, 2017 — More than 50 companies and organizations will display their latest products and services at the Americ
Memorial Hospital of Gulfport used a McKesson, Change Healthcare, cardiovascular information system (CVIS) to improve workflow efficiency

Memorial Hospital has increased efficiency using a single cardiovascular information management database. 

Sponsored Content | Case Study | Cardiac PACS| May 23, 2017
Located along Mississippi’s Gulf Coast, Memorial Hospital at Gulfport is a nonprofit, 445-bed facility originally est
DASpecialists and Lumedx partner for data abstraction and support services for cardiovascular registries, NCDR, ACC, STS
News | Cardiac PACS| May 05, 2017
May 5, 2017 — DASpecialists LLC, a provider of data abstraction and support services for mandated or voluntary cardio

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
Sponsored Content | Videos | Analytics Software| April 13, 2017
The shift to value-based payment models requires focused attention on quality and cost.
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
AI, deep learning, artificial intelligence, medical imaging, cardiology, echo AI, clinical decision support, echocardiography

An example of artificial intelligence from the start-up company Viz. The image shows how the AI software automatically reviews an echocardiogram, completes an automated left ventricular ejection fraction quantification and then presents the data side by side with the original cardiology report. The goal of the software is to augment clinicians and cardiologists by helping them speed workflow, act as a second set of eyes and aid clinical decision support.

Feature | Artificial Intelligence| March 10, 2017 | Dave Fornell
Artificial intelligence (AI) has captured the imagination and attention of doctors over the past couple years as seve
Sponsored Content | Videos | HIMSS| March 10, 2017
ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo flo
Overlay Init